We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published bySammy Aguillard
Modified over 2 years ago
0 This document is CONFIDENTIAL and its distribution and use are RESTRICTED © 2012 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (‘KPMG International’), a Swiss entity. All rights reserved. CV Professor Hilary Thomas NameProfessor Hilary Thomas PositionPartner and Clinical Lead – Life Sciences and Healthcare Advisory and Global Centre of Excellence ExperienceHilary qualified in 1984 and pursued a career in oncology from Senior Lecturer at Imperial to Professor of Oncology at the University of Surrey where she led a basic science research group and was a keen contributor to clinical trials of all Phases as well as a Key Opinion Leader in breast cancer and gynaecological malignancies. She has published over 80 papers and led research teams in the HEFC Research Assessment Exercise. She became Medical Director of a Cancer Network until 2004 and then Medical Director of the Royal Surrey County Hospital. She was an elected member of the General Medical Council from 1994-2003 during which she chaired the committee on standards and medical ethics and gave evidence to Select Committees of both Houses of Parliament. Hilary leads our global health proposition, Care System Redesign working across regional health ecosystems to redesign inter- organisational patient pathways and shift the provision of care to more appropriate settings. Hilary is the most senior clinician within our Life Sciences and Health practice – working with the ABPI on their approach to Big Data and with a devices firm to develop a modular, global service specification for a clinical condition.She also leads on clinical engagement and clinical service redesign across a range of engagements including whole system transformation programmes across several health economies to deliver reconfiguration to ensure sustainable aligned services. She leads on telemedicine, e-health and m-health and interfaces with the Department of Health on the Three Million Lives Campaign on telehealth and telecare. She has been supporting the National Specialist Commissioning Team with the reconfiguration of paediatric cardiac surgical services since 2010. In the past year she has overseen nearly 40 quality governance reviews in the NHS and has worked with Monitor to reviews several aspirant FTs. Prior to KPMG Hilary was Group Medical Director of Care UK where she led on clinical governance across the Group. She was a Leadership Associate of the Kings Fund from 2008-10 and taught on the SpRs and NHS Management Trainee programmes Hilary was a member of the Healthcare for London Clinical Advisory Group from 2007-10. She has been a Trustee of Breakthrough Breast Cancer since 2007 and Vice Chair since 2008. she is also a Trustee of Imperial Healthcare Charity. QualificationsMB BS MA, Cantab Fellow of the Royal College of Radiologists Fellow of the Royal College of Physicians PhD – in the biology of breast cancer
KPMG-Refugee Council Partnership Deb Conner and Nicole Masri 4 December 09.
Cancer Research UK strategy and funding Simon Vincent.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
Better care together Staff information July 2015.
Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.
NDAU/NNAP Collaborators Meeting Neena Modi Professor of Neonatal Medicine Imperial College London Vice President, Science & Research Royal College of Paediatrics.
MLCF IMPLEMENTATION AND FUTURE DEVELOPMENTS Professor Peter Spurgeon University of Warwick Medical School Project Director, Enhancing Engagement in Medical.
The NHS Reforms – a Policy Analyst’s View
How to find a fellowship Dr Cheok-man Chow Research Funding, Cancer Research UK.
Technology in Health Service Transformation Stephen Johnson Deputy Director – Head of Long Term Conditions Department of Health
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
The Workforce, Education Commissioning and Education and Learning Strategy Enabling world class healthcare services within the North West.
Fellowships Day at Imperial College Sarah Fox 3 rd July 2007.
South Thames Foundation School Faculty Briefing 29 th January 2010.
Breakthrough to real change in local healthcare Dr Patricia Hamilton Director of Medical Education.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
Actuaries in China 2 nd December © 2010 KPMG LLP, a UK limited liability partnership, is a subsidiary of KPMG Europe LLP and a member firm of.
Warwick CTU 10 th Anniversary Presentation Professor Tom Walley.
NHS West Kent Clinical Commissioning Group West Kent Urgent Care DRAFT Strategy Delivering a safe and sustainable urgent care system by
SHAPING FUTURE SERVICE Dr Sarah Schofield GP Chairman West Hampshire Clinical Commissioning Group.
© 2017 SlidePlayer.com Inc. All rights reserved.